<p>(<b>A</b>) BUD patients were divided into fast healers (≤ 111 days) and slow healers (> 111 days) based on the time required for complete healing and proportions of cytokine producing CD4+ T cells (<b>B</b>, <b>C</b>) or lesion sizes (<b>D</b>) are compared by non-parametric Mann Whitney <i>U</i> test. The healing rate within the first four weeks (in change if mm/week) was correlated with TNFα+CD40L-IFNγ- CD4+ T cells (<b>E</b>) by Spearman correlation or compared based on time until healing process starts after initiating antibiotic treatment (<b>F</b>).</p
<div><p>Background</p><p>Following introduction of antimycobacterial treatment of Buruli ulcer disea...
International audienceBuruli ulcer disease (BUD) is an emerging human disease caused by infection wi...
Introduction: Ulcer of Buruli is a skin disorder due to Mycobacterium ulcerans. The objective was to...
-specific CD4+ T cell responses in BUD patients and to analyse specific cytokine-producing T cells i...
<div><p>Background</p><p>Buruli ulcer disease (BUD), caused by <i>Mycobacterium (M</i>.<i>) ulcerans...
Buruli ulcer disease (BUD) is an emerging predominantly tropical disease caused by Mycobacterium ulc...
INTRODUCTION: Wound measurements are relevant in monitoring the rate of healing (RoH) and may predic...
Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, follows an indolent course of initial ...
Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, follows an indolent course of initial ...
<div><p>Introduction</p><p>Buruli ulcer (BU) caused by <i>Mycobacterium ulcerans</i> is effectively ...
While traditionally surgery has dominated the clinical management of Buruli ulcer (BU), the introduc...
<p>Blue line: Median time (weeks) for detection of <i>M</i>. <i>ulcerans</i> 16S rRNA. Red line: Pro...
Buruli ulcer (BU) caused by Mycobacterium ulcerans is effectively treated with rifampicin and strept...
Cutaneous leishmaniasis (CL) is a worldwide disease endemic in several regions of the globe. The hal...
While traditionally surgery has dominated the clinical management of Buruli ulcer (BU), the introduc...
<div><p>Background</p><p>Following introduction of antimycobacterial treatment of Buruli ulcer disea...
International audienceBuruli ulcer disease (BUD) is an emerging human disease caused by infection wi...
Introduction: Ulcer of Buruli is a skin disorder due to Mycobacterium ulcerans. The objective was to...
-specific CD4+ T cell responses in BUD patients and to analyse specific cytokine-producing T cells i...
<div><p>Background</p><p>Buruli ulcer disease (BUD), caused by <i>Mycobacterium (M</i>.<i>) ulcerans...
Buruli ulcer disease (BUD) is an emerging predominantly tropical disease caused by Mycobacterium ulc...
INTRODUCTION: Wound measurements are relevant in monitoring the rate of healing (RoH) and may predic...
Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, follows an indolent course of initial ...
Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, follows an indolent course of initial ...
<div><p>Introduction</p><p>Buruli ulcer (BU) caused by <i>Mycobacterium ulcerans</i> is effectively ...
While traditionally surgery has dominated the clinical management of Buruli ulcer (BU), the introduc...
<p>Blue line: Median time (weeks) for detection of <i>M</i>. <i>ulcerans</i> 16S rRNA. Red line: Pro...
Buruli ulcer (BU) caused by Mycobacterium ulcerans is effectively treated with rifampicin and strept...
Cutaneous leishmaniasis (CL) is a worldwide disease endemic in several regions of the globe. The hal...
While traditionally surgery has dominated the clinical management of Buruli ulcer (BU), the introduc...
<div><p>Background</p><p>Following introduction of antimycobacterial treatment of Buruli ulcer disea...
International audienceBuruli ulcer disease (BUD) is an emerging human disease caused by infection wi...
Introduction: Ulcer of Buruli is a skin disorder due to Mycobacterium ulcerans. The objective was to...